VPS35 and Parkinson disease: Thus, our genetic studies suggest that vps35 variants associated with PD are likely to confer pathogenicity by haploinsufficiency rather than a toxic gain of function and suggest that mitochondrial quality control may be an important pathway in vps35-meditated pathogenesis.